Sat, Aug 23, 2014, 2:44 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

IntelliCell BioSciences, Inc. Message Board

  • athec_99 athec_99 Jun 27, 2014 10:45 AM Flag

    FDA Form 483, back to the 'science'

    There are no written procedures for production and process controls designed to assure that the DRUG PRODUCTS have the identity, strength, quality and purity they purport or are represented to possess.
    Specifically, a) during the Stromal Vascular Fraction manufacturing process (b)4 solution is added to the SVF process. Your procedure does not specify how this reagent is prepared and tested. b) Your firm manufactures a Stromal Vascular Fraction using (b)4. The stem cells are separated from adipose fat by centrifugation. However, there are no procedures in place and no documentation maintained showing validation and established working parameters for your Ultrasonic Processor.
    Notice the words 'DRUG PRODUCTS'.
    Interpretation: Dr. LookGood can't explain to the FDA what he has concocted in the flow cytometer machine from Miilipore and how he has concocted them. In other words, 'snake oil in a syringe'.

    Sentiment: Strong Sell

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Wouldn't you be better served getting some of those fat deposits removed from your arteries that are about ready to drop you? Sitting on you tail all day eating fat infested food spilled over you posting can't be good for you. Get out and exercise and eat healthy you lethargic lunk of #$%$. Those fat deposits have made it to your brain.

 
SVFC
0.0014+0.0001(+7.69%)Aug 22 3:53 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Keurig Green Mountain, Inc.
NasdaqGSFri, Aug 22, 2014 4:00 PM EDT
Amicus Therapeutics, Inc.
NasdaqGMFri, Aug 22, 2014 4:00 PM EDT